InvestorsHub Logo
Followers 6
Posts 233
Boards Moderated 0
Alias Born 10/05/2011

Re: Cave In Temptor post# 3417

Tuesday, 07/15/2014 6:18:28 PM

Tuesday, July 15, 2014 6:18:28 PM

Post# of 4817
Thanks as well, Cave In Temptor!

Also and as an fyi: the Medac / BD Physioject device could be referred to as a market available subQ injector for any end user who wishes to enlist BD, enter an agreement and use.

http://www.bd.com/pharmaceuticals/products/self-injection/auto-injectors.asp


This is what Medac did with this injector. This is also what EMD Serono is using for their MS drug, Rebif Rebidose.

http://www.rebif.com/pages/starting-rebif/rebif_rebidose

Also, Bristol Myers Squibb is using the BD Physioject in this Ph 1 study for using "Abatacept (Orencia) is a drug used to treat inflammatory signs of arthritis, such as pain, swelling and prolonged joint stiffness. Abatacept belongs to the biologic class of drugs, which means that it works similarly to natural substances in the immune system.

Like other biologic drugs, abatacept was created with genetic-engineering techniques. It helps decrease inflammation in arthritis.

FAST FACTS
Abatacept is a second-line drug that often is used when disease-modifying anti-rheumatic drugs, such as methotrexate, and/or other biologic drugs have failed to control inflammatory arthritis.
No higher risk of serious infections was reported with abatacept compared to other biologic drugs. Further long-term studies are needed.
Reports did not show higher risks of cancer in patients on abatacept. Larger study groups and long-term study will clarify this. Risks in pregnant women are still being studied."

http://clinicaltrials.gov/ct2/show/NCT01890473?term=Physioject&rank=1